The latest moves by QFII (Qualified Foreign Institutional Investors), among the most representative foreign institutions in China's A-share market, have come to light as third-quarter reports conclude. Data shows QFII holdings in A-shares now exceed 150 billion yuan (approximately $20.9 billion).

At the end of Q3, 160 stocks held by QFII were valued over 100 million yuan each, with nine exceeding 1 billion yuan. Top holdings include Bank of Ningbo, Bank of Nanjing, and Shengyi Technology.

Bank of Ningbo and Bank of Nanjing lead with QFII holdings worth 34.93 billion yuan and 23.17 billion yuan respectively. Both banks, which went public on the same day in July 2007, have maintained consecutive annual profit growth. Their net profits for the first three quarters hit record highs of 22.45 billion yuan and 18.01 billion yuan respectively.

Shengyi Technology, specializing in copper-clad laminates and printed circuit boards for AI servers, 5G, and automotive electronics, saw QFII holdings worth 15.94 billion yuan. Its net profit surged 78.04% YoY to 2.44 billion yuan in Q1-Q3.

QFII newly added or increased positions in 114 stocks during Q3. Zhongce Rubber saw the most significant increase, with QFII acquiring a 10.76% stake, joined by Merrill Lynch, JPMorgan, and Morgan Stanley as major shareholders.

Other notable new QFII entries include Lixing Shares (7.17%), Boyuan Shares (7.1%), and Yangdian Technology (4.86%). These companies lead in precision bearing components, iodine compounds, and energy-efficient transformers respectively.

Among QFII's new picks, 37 stocks have more than doubled year-to-date. Shangwei New Materials leads with a staggering 1487.7% surge after Zhirui Robotics acquired a 63.62% controlling stake. Tianpu Shares rose 640.9% amid semiconductor sector hype, though it clarified no backdoor listing plans. Huijin Shares gained 309.91% despite consecutive annual losses exceeding 200 million yuan since 2022.

Valuation metrics show 23 of these QFII-favored stocks trade below 30x P/E, including Bank of Nanjing and Meihua Biological under 10x. Thirteen offer dividend yields above 2%, led by Meihua Biological (5.42%) and Dong-E-E-Jiao (5.35%).